Shed is direct about what it offers. The name signals the goal, and the platform delivers on it without lifestyle branding or coaching programs that most patients are not going to use anyway. Compounded semaglutide and tirzepatide, licensed provider oversight, competitive pricing. In a GLP-1 market where platforms increasingly justify higher prices with wellness add-ons, Shed's bet is that most people just want the medication to work. If you want an effective prescription weight loss program at a low price without extras, Shed is that.
What Shed Offers and How It Works
Shed provides compounded semaglutide and compounded tirzepatide through a standard telehealth model. You complete an online intake covering your health history, BMI, current medications, and weight loss goals. A licensed provider reviews your submission and issues a prescription if you qualify. The medication ships from a licensed compounding pharmacy directly to your door.
The standard semaglutide titration protocol at Shed starts at 0.25mg weekly, stepping up every 4 weeks based on your tolerance and response. The goal is to reach the dose where appetite suppression is meaningful without GI side effects being severe enough to interfere with daily life. Most patients spend 12-16 weeks reaching their maintenance dose of 1.0-2.4mg weekly.
Monthly provider check-ins are included in the subscription. These appointments confirm you are tolerating the current dose, assess your weight loss progress, and make dosing decisions for the next month. Between check-ins, messaging support is available through the platform for side effect questions or concerns.
What Shed does not build into the program: structured nutrition coaching, one-on-one dietitian sessions, exercise programming, or a behavioral health component. The platform covers the medical side of GLP-1 treatment. The lifestyle work is on you.
Compounded Semaglutide vs Tirzepatide at Shed
Compounded semaglutide - the
same active ingredient as Wegovy and Ozempic - is Shed's primary offering. Clinical trial data from the STEP program showed average weight loss of 14.9% of body weight over 68 weeks at the 2.4mg maintenance dose. For a 230-pound person, that's roughly 34 pounds. The medication works by activating GLP-1 receptors, reducing appetite, slowing gastric emptying, and improving insulin sensitivity.
Compounded tirzepatide - same active ingredient as Zepbound and Mounjaro - activates both GLP-1 and GIP receptors. The SURMOUNT-1 trial showed average weight loss of 20.9% at the highest dose over 72 weeks, making tirzepatide the more potent option for patients who tolerate it. Shed's tirzepatide is priced higher than semaglutide, consistent with the broader market.
For patients starting GLP-1 treatment for the first time without prior experience with either medication, Shed providers typically recommend beginning with semaglutide. The longer real-world track record, well-understood side effect profile, and lower cost make it the natural starting point. Tirzepatide is often recommended for patients who have tried semaglutide with insufficient weight loss response or for those who specifically request it.
Pricing and What You Actually Pay
Shed's pricing is positioned at the competitive end of the compounded GLP-1 market. Compounded semaglutide starts at approximately $149 per month at the introductory dose, with pricing stepping up as doses increase - typically reaching $199-229 per month at higher therapeutic doses. Tirzepatide is priced at approximately $199-249 per month.
The monthly fee covers the medication, shipping, and provider check-in. There are no separate consultation fees, and no additional charges for the messaging support between appointments. What you pay per month is what you pay.
Shed operates on a cash-pay model - no insurance billing, no prior authorization navigation, no insurance paperwork. This is standard for compounded GLP-1 platforms because compounded medications are not covered by insurance formularies. If you have insurance coverage for branded Wegovy or Zepbound through your employer plan, a platform that helps with prior authorization (like PlushCare or Ro) might save you money. For everyone else, Shed's cash-pay pricing is competitive.
HSA and FSA cards are accepted. For patients in higher tax brackets, using pre-tax health account dollars for GLP-1 treatment reduces the effective monthly cost meaningfully - a patient in the 32% bracket pays effectively $136-156 per month when using an HSA for a $200 Shed subscription.
Medication Quality and Sourcing
Shed sources compounded semaglutide and tirzepatide from
FDA-registered 503B outsourcing facilities. This regulatory designation matters for compounded injectable medications. 503B facilities are subject to FDA inspection, must follow current Good Manufacturing Practice standards, and conduct batch testing for sterility, potency, and contamination. The distinction between 503B and unregulated compounders is the difference between medication that meets pharmaceutical-grade production standards and medication that does not.
The medication is shipped as pre-filled injection pens or vials depending on dose and availability. Injection training materials are included with the first shipment, and the provider check-in system allows for injection technique questions if you are new to self-administered subcutaneous injections.
Proper storage matters for compounded semaglutide: refrigerate at 36-46°F upon arrival and do not freeze. Shed ships with appropriate cold-chain packaging. Plan to be available to receive the first shipment or have it held at a secure location.
The FDA has issued guidance on the regulatory status of compounded GLP-1 medications that has evolved as the branded shortage designation has changed. Patients using compounded GLP-1 medications should be aware that the regulatory landscape for compounding is subject to change, which could affect availability.
Managing Side Effects on Shed
Who Shed Is Best Suited For
Shed works best for a specific patient profile: adults who meet GLP-1 eligibility criteria (
BMI 30+ or BMI 27+ with a weight-related comorbidity), are comfortable with the self-injection process, do not require structured behavioral support to make dietary changes, and want medication-forward access at a competitive price.
The platform is a natural fit for patients who have done their homework on GLP-1 medications and want to get started efficiently rather than navigating a complex intake process or paying for program features they do not intend to use. If you already understand how semaglutide works, what the titration schedule looks like, and what dietary adjustments support the medication, Shed delivers the prescription access without the overhead.
Shed is less suited for patients who need significant behavioral support alongside the medication - those who want weekly dietitian check-ins, structured meal planning, or fitness coaching integrated into their program. For that level of support, platforms like Ro Body or dedicated medical weight loss programs provide more infrastructure at a higher price point.
Patients with complex metabolic conditions - type 2 diabetes requiring careful HbA1c monitoring, kidney disease affecting medication metabolism, or cardiovascular history needing close clinical oversight - benefit from a platform with more capable lab monitoring integration than Shed currently offers.
Long-Term Weight Maintenance Considerations
Shed providers discuss this reality during check-ins as patients approach their goal weight. The options are: continue at a maintenance dose indefinitely, attempt gradual dose reduction with careful monitoring, or transition to behavioral strategies that may support weight maintenance without medication. The evidence for the third option is limited - the biological drivers of weight regain (increased appetite, reduced energy expenditure, altered gut hormones) are suppressed by the medication and reassert themselves when it is removed.
For patients who plan to use Shed long-term, the monthly cost is a meaningful financial commitment. At $149-229 per month, ongoing GLP-1 treatment costs $1,800-2,750 annually. Over five years, that is $9,000-13,750. This is far less than branded Wegovy or Zepbound at $15,000-17,000 over the same period, but it is a real ongoing expense to plan for.
The good news: patients who reach and maintain goal weight on a lower maintenance dose may be able to reduce costs. Shed providers can adjust dosing based on clinical response, and some patients maintain their results at doses lower than their maximum titration level.
Shed vs Other Weight Loss Platforms
In the competitive compounded GLP-1 market, Shed positions alongside iVIM Health, Skinny.Rx, and MyStart Health as a lower-cost, medication-focused option. The differentiators come down to pricing, support depth, and platform experience.
Against Henry Meds and Ro Body - which offer more capable clinical support, lab integration, and dietary coaching - Shed is less expensive but provides less structured support. If you value monthly nutrition counseling or integrated lab monitoring, the price premium at those platforms is justified by the services you receive.
Against hims, which charges $199-299 per month for semaglutide with quarterly check-ins, Shed's comparable pricing with monthly check-ins represents better clinical contact frequency.
The clearest advantage Shed has over most competitors is simplicity. The intake is straightforward, the pricing is transparent, and the clinical model is clean. There are no upsells, no add-on packages, no app features requiring engagement to access the subscription value. For patients who want uncomplicated access to a medication they have already decided to try, that simplicity is a genuine feature.
Frequently Asked Questions
How much does Shed cost per month?
Compounded semaglutide starts at approximately $149 per month at the introductory dose, reaching $199-229 per month at higher doses. Tirzepatide starts at approximately $199-249 per month. Monthly provider check-ins are included with no separate fees.
Does Shed accept insurance?
No. Shed is a cash-pay platform. Compounded medications are not covered by insurance. HSA and FSA cards are accepted.
What medications does Shed offer?
Shed offers compounded semaglutide (same active ingredient as Wegovy and Ozempic) and compounded tirzepatide (same active ingredient as Zepbound and Mounjaro). Both are available as weekly subcutaneous injections.
Who qualifies for Shed?
Adults with BMI 30 or higher, or BMI 27 or higher with a weight-related health condition (type 2 diabetes, hypertension, high cholesterol, sleep apnea). People with a history of medullary thyroid cancer, pancreatitis, or pregnancy do not qualify.
How often do I speak with a provider at Shed?
Monthly check-ins are included in the subscription. Between check-ins, messaging support is available for side effect questions and clinical concerns.
Does Shed offer nutrition coaching?
No. Shed focuses on the medical side of GLP-1 treatment - prescription, medication, and provider oversight. Structured nutrition coaching is not part of the program.
How is the semaglutide at Shed sourced?
Shed sources from FDA-registered 503B outsourcing facilities that meet current Good Manufacturing Practice standards, including batch testing for sterility and potency.
How long until I see results with Shed?
Appetite suppression typically begins in the first 1-2 weeks. Meaningful weight loss usually appears in weeks 4-8 as doses increase. Clinical trials show average weight loss of 14.9% of body weight over 68 weeks on semaglutide.
Can I cancel my Shed subscription?
Yes. Subscriptions can be cancelled anytime without contracts or cancellation fees.
What side effects should I expect at Shed?
Nausea, constipation, diarrhea, and reduced appetite are most common during dose escalation. These typically improve within 2-3 weeks at each new dose level. Shed providers can prescribe antiemetics if nausea is severe.
Does Shed offer tirzepatide?
Yes. Compounded tirzepatide is available at approximately $199-249 per month. Providers recommend the appropriate medication based on your health history.
Is Shed available in my state?
Shed operates in most US states. Check the Shed website for current state-specific availability.
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
